Publications by authors named "Yoeri Schrooten"

Claim this Profile
P
Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes.
Kasper T Christensen, Florian Pierard, David Bonsall, Rory Bowden, Eleanor Barnes, Yoeri Schrooten

Viruses· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort.
Kasper T Christensen, Florian Pierard, Kurt Beuselinck, David Bonsall, Rory Bowden, Yoeri Schrooten

J Clin Virol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning.
Lize Cuypers, Pieter Libin, Yoeri Schrooten, Kristof Theys, Velia Chiara Di Maio

Infect Genet Evol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy.
Lize Cuypers, Bram Vrancken, Lavinia Fabeni, Nadia Marascio, Valeria Cento, Yoeri Schrooten

BMC Evol Biol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of antiviral drug resistance and non-b subtypes in HIV-1 patients failing antiviral therapy in Cuba.
Vivian Kouri, Yoan Alemán, Lissette Pérez, Jorge Pérez, Carlos Fonseca, Yoeri Schrooten

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of an in-house human immunodeficiency virus type 1 genotyping system for assessment of drug resistance in Cuba.
Yoan Alemán, Lore Vinken, Vivian Kourí, Lissette Pérez, Alina Álvarez, Yoeri Schrooten

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.
Andrea-Clemencia Pineda-Peña, Yoeri Schrooten, Lore Vinken, Fossie Ferreira, Guangdi Li

PLoS One· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits.
Sarah Megens, Dolores Vaira, Greet De Baets, Nathalie Dekeersmaeker, Yoeri Schrooten

Virology· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the automatic editing tool RECall for HIV-1 pol and V3 loop sequences.
Lore Vinken, Sarah Megens, Yoeri Schrooten, Anne-Mieke Vandamme, Kristel Van Laethem

J Virol Methods· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba.
Lissette Pérez, Vivian Kourí, Yoan Alemán, Yeisel Abrahantes, Consuelo Correa, Yoeri Schrooten

Infect Genet Evol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba.
Vivian Kourí, Yoan Alemán, Lissette Pérez, Jorge Pérez, Carlos Fonseca, Yoeri Schrooten

J Clin Virol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel recombinant virus assay for measuring susceptibility of human immunodeficiency virus type 1 group M subtypes to clinically approved drugs.
Kris Covens, Nathalie Dekeersmaeker, Yoeri Schrooten, Jan Weber, Dominique Schols

J Clin Microbiol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes.
Kris Covens, Kabamba Kabeya, Yoeri Schrooten, Nathalie Dekeersmaeker, Eric Van Wijngaerden

J Clin Virol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.
Kristel Van Laethem, Yoeri Schrooten, Kris Covens, Nathalie Dekeersmaeker, Paul De Munter

J Virol Methods· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.
Jurgen Vercauteren, Inge Derdelinckx, André Sasse, Marleen Bogaert, Helga Ceunen, Yoeri Schrooten

AIDS Res Hum Retroviruses· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs.
Kristel Van Laethem, Paul De Munter, Yoeri Schrooten, Rene Verbesselt, Marc Van Ranst

J Clin Virol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genotypic assay for the amplification and sequencing of gag and protease from diverse human immunodeficiency virus type 1 group M subtypes.
Kristel Van Laethem, Yoeri Schrooten, Sarah Dedecker, Lies Van Heeswijck, Koen Deforche

J Virol Methods· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular testing of multiple HIV-1 transmissions in a criminal case.
Philippe Lemey, Sonia Van Dooren, Kristel Van Laethem, Yoeri Schrooten, Inge Derdelinckx

AIDS· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene.
Kristel Van Laethem, Yoeri Schrooten, Philippe Lemey, Eric Van Wijngaerden, Stéphane De Wit

J Virol Methods· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.
Inge Derdelinckx, Kristel Van Laethem, Bart Maes, Yoeri Schrooten, Stéphane De Wit

J Acquir Immune Defic Syndr· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory.
Bart Maes, Yoeri Schrooten, Joke Snoeck, Inge Derdelinckx, Marc Van Ranst

J Virol Methods· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001.
Joke Snoeck, Kristel Van Laethem, Philippe Hermans, Eric Van Wijngaerden, Inge Derdelinckx, Yoeri Schrooten

J Acquir Immune Defic Syndr· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes.
Inge Derdelinckx, Kristel Van Laethem, Bart Maes, Yoeri Schrooten, Kirsten De Schouwer

FEMS Immunol Med Microbiol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure.
Kristien Van Vaerenbergh, Sabina De Geest, Inge Derdelinckx, Herman Bobbaers, An Carbonez, Yoeri Schrooten

Antivir Chem Chemother· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis